This article has been updated to include a statement from Illumina.

NEW YORK (GenomeWeb News) - Life Technologies and several co-plaintiffs this week filed suit against Illumina for allegedly infringing three DNA-amplification patents.

The suit, filed in the US District Court for the District of Delaware, claims that Illumina and Solexa, which Illumina acquired in 2007, infringe US Patent Nos. 5,616,478; 5,989,698; and 6,001,568. All three patents relate to amplifying nucleic acids in a solid medium.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.